Miami Cancer Institute at Baptist Health South Florida is a clinical research site located in Miami, Florida, United States 33176.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Miami Cancer Institute at Baptist Health South Florida has participated in 10 clinical trials with 7 currently active.
Therapeutic areas: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Brain Metastases, Brain Cancer.
Sponsors: MeiraGTx, LLC, Baptist Health South Florida, Bayer.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Miami Cancer Institute at Baptist Health South Florida has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Miami Cancer Institute at Baptist Health South Florida has 10 clinical trials on record, with 7 currently active. Their work covers Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Brain Metastases, Brain Cancer.
Yes — Miami Cancer Institute at Baptist Health South Florida holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.